课题基金 / 基金详情

Effects of Antiretrovirals on Neuronal Health: Screening ARVs for Neurotoxicity

Effects of Antiretrovirals on Neuronal Health: Screening ARVs for Neurotoxicity
抗逆转录病毒药物对神经元健康的影响:筛选抗逆转录病毒药物的神经毒性
批准号:
9220695
负责人:
Paul S Garcia
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-10-01 至 2018-09-30
关键词:
AcuteAdverse effectsAfferent NeuronsAnatomyAnesthesia proceduresAnimal BehaviorAnimal ModelAnimalsAnti-HIV AgentsAnti-Retroviral AgentsAwardBathingBehavioralBiophysicsBrainBrain regionCaringCentral Nervous System AgentsChronicClinicalClinical ResearchCognitiveCognitive deficitsComplexConfusionDataDementiaDepressed moodDetectionDeteriorationDeveloped CountriesDisabled PersonsDrug ExposureDrug usageFunctional disorderFundingFutureGoalsHIVHIV InfectionsHIV SeropositivityHIV-associated neurocognitive disorderHealthHealth Services AccessibilityHippocampus (Brain)Impaired cognitionImpairmentIn VitroIncidenceInfectionInflammationInterruptionInvestigationKnowledgeLaboratoriesLeadLong-Term PotentiationMalaiseMeasurableMeasuresMediatingMedicalMembraneMemoryMemory LossMemory impairmentMentorsMethodsModalityModelingMorphologyNeuraxisNeurocognitiveNeurocognitive DeficitNeurologicNeurologic EffectNeurologic SymptomsNeuronsNeuropsychological TestsNeurosciencesOperative Surgical ProceduresOutcomePatientsPeripheral Nervous System DiseasesPharmaceutical PreparationsPharmacologyPharmacotherapyPhylogenetic AnalysisPhysiologicalPhysiologyPlayPopulationPrevalenceProviderQuality of lifeRadialRegimenResearchRoleScienceSecureSignal TransductionSliceStructureStudy modelsSynaptic TransmissionTechniquesTemporal LobeTestingTherapeutic AgentsToxic effectTrainingTranslatingTranslational ResearchUnited StatesVeteransViral Load resultWaterWorkantiretroviral therapyarmbehavior testbrain tissuecognitive changecognitive taskcombatcostdesigndrug modificationeconomic impactexperimental studyimmune system functionimprovedin vivoin vivo Modelmild cognitive impairmentnervous system disorderneuronal excitabilityneurophysiologyneurotoxicneurotoxicityneurotransmissionnovelobject recognitionpre-clinicalprogramspublic health relevancescreeningskillsspatiotemporalsubcutaneoussymptomatologytooltreatment strategy

项目摘要

项目成果

Paul S Garcia的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供): 大约50%的艾滋病毒阳性退伍军人发展艾滋病毒相关的神经认知障碍,或手,尽管充分的抗艾滋病毒药物治疗。与艾滋病毒感染相关的神经系统疾病包括无症状的神经认知障碍(只能通过复杂的神经心理学测试检测到)和明显的痴呆症。在像美国这样的工业化国家,逆转录病毒药物治疗已经降低了由于HIV感染导致的严重痴呆症的发病率,但HAND的患病率却意外上升(特别是在较温和的形式中)。其原因尚不清楚;然而,新的数据表明,用于对抗HIV感染的抗逆转录病毒药物(ARV)可能独立产生中枢神经系统(CNS)毒性,并导致不良神经系统疾病的患病率增加。轻度的HAND更常见,发病时更阴险,可能会在精神上影响退伍军人保持健康和经济安全的能力。令人惊讶的是,抗逆转录病毒药物对中枢神经系统神经元功能信号的直接影响还有待研究。通过这笔资金,我们有机会填补这一知识空白。大多数累积的证据表明抗HIV药物可能涉及认知功能障碍,这些证据是从涉及感觉神经元的体外实验中推断出来的,或者是从临床研究中推断出来的,这些临床研究的设计大多是观察性的。了解我们的艾滋病毒治疗的潜在不利影响的机制是减少其对健康的负面影响的唯一途径。这项研究的主要目的是在没有炎症或感染的情况下检查抗逆转录病毒药物对中枢神经系统神经元的毒性。这将通过生理学,解剖学和行为学的方法进行研究。通过临床前研究确定神经毒性的机制,我们可以开始为ARV治疗的这些并发症开发合理的治疗方法,并调整药理学方案,以减少对现有认知功能障碍患者的CNS毒性作用。由于HAND可能首先表现为时空记忆任务中的轻度认知障碍,我们的研究工作将集中在这些已知与记忆任务密切相关的大脑皮层区域。拟议工作的基本假设是,尽管它们在减少艾滋病毒载量方面有效,但某些临床上与周围神经病变相关的抗逆转录病毒药物也会损害正常的皮质神经元解剖学、生理学和突触传递,这些神经生理学效应将导致急性或慢性暴露的记忆相关任务发生可测量的变化。为了验证我的假设,我建议将不同的ARV子集(8种独立的药物)进行一系列体外和体外实验,以确定这些药物对皮质神经元树突分支、兴奋性和网络活动的影响;从而建立一个潜在毒性ARV的生物物理学特征。然后,我将使用记忆中断的体内行为测试来验证神经毒性的生物物理预测因子。然后建立一个有效的生物物理筛选ARV介导的神经毒性,使用最简单的生物物理测试模式,预测最严重的记忆障碍测量整个动物。最后,我将只对所有常用的抗逆转录病毒药物应用必要的筛选工具,以简化神经毒性检测的方法。通过这个指导奖,我将扩展我的实验室技能,超越我的神经生理学背景,包括行为和神经解剖技术。一旦配备了必要的工具箱,我打算开发一个独立的科学计划,专注于将药理学测试转化为指导神经科学的临床决策。
英文摘要
DESCRIPTION (provided by applicant): Approximately 50% of HIV positive veterans develop HIV associated neurocognitive disorders, or HAND, despite adequate anti-HIV drug therapy. The neurologic disease associated with HIV infection ranges from asymptomatic neurocognitive impairment, only detected by sophisticated neuropsychological testing, to frank dementia. In industrialized nations like the United States, retroviral pharmacotherapy has reduced the incidence of severe dementia due to HIV infection, but the prevalence of HAND has unexpectedly risen (especially among the milder forms). The reason(s) for this is unclear; however, new data suggest that the antiretroviral agents (ARVs) used to combat HIV infection may independently exert central nervous system (CNS) toxicities and contribute to this increased prevalence of adverse neurologic symptomatology. The milder forms of HAND are more common, more insidious in their onset and can detrimentally impact a veteran's ability to remain healthy and financially secure. Surprisingly, the direct effects of ARV on functional signaling of CNS neurons has yet to be examined. Through this funding, we have the opportunity to fill that knowledge gap. The majority of the accumulated evidence that implicates anti-HIV drugs as potentially involved in cognitive dysfunction is inferred from in vitr experiments involving sensory neurons or derived from clinical studies that are mostly observational in their design. Understanding the mechanisms of the potential adverse effects of our treatments for HIV is the only way to minimize their negative impact on health. The primary goal of the proposed research is to examine ARVs for CNS neuronal toxicity in the absence of inflammation or infection. This will be investigated through physiological, anatomical, and behavioral approaches. By determining mechanisms of neurotoxicity in preclinical investigations, we can begin to develop rational treatments for these complications of ARV therapy and to adapt pharmacologic regimens to involve less toxic CNS effects in patients with existing cognitive dysfunction. As HAND may first manifest as mild cognitive impairment in spatiotemporal memory tasks, our research efforts will focus on these cortical brain regions known to be closely associated with memory tasks. The underlying hypotheses of the proposed work is that despite their efficacy in reducing HIV load, certain ARVs clinically associated with peripheral neuropathy will also impair normal cortical neuron anatomy, physiology, and synaptic transmission and these neurophysiological effects will lead to measurable changes on memory-associated tasks either acutely or via chronic exposure. To test my hypotheses, I am proposing to subject a diverse subset of the ARVs (8 separate drugs) to a battery of in vitro and ex vivo experiments in order to determine the effects of these drugs on the dendritic branching, excitability, and network activity of cortical neurons; thus establishing a biophysical profile of potentially toxic ARV. I will then validate biophysical predictors of neurotoxicity using in vivo behavioral testing of memory disruption. And then establish an efficient biophysical screen for ARV-mediated neurotoxicity using the simplest biophysical testing modality which predicts the most severe memory impairments measured in the whole animal. Finally, I will apply only the necessary screening tools to all of the commonly prescribed ARVs to streamline the method of neurotoxicity detection. Through this mentored award, I will extend my laboratory skills beyond my background in neurophysiology to include behavioral and neuroanatomical techniques. Once armed with the necessary toolbox, I intend to develop an independent science program focusing on translating pharmacological testing to guiding clinical decisions in the neurosciences.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of Antiretrovirals on Neuronal Health: Screening ARVs for Neurotoxicity
  • 批准号:
    8763870
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2013
  • 负责人:
    Paul S Garcia
  • 依托单位:
Effects of Antiretrovirals on Neuronal Health: Screening ARVs for Neurotoxicity
  • 批准号:
    8541476
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2013
  • 负责人:
    Paul S Garcia
  • 依托单位:
海外基金